Regenxbio Inc
RGNX
NASDAQ
Biotechnology
$10.77
USD
+0.11 (+0.98%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $701.72M
Volume 792.3K
Price Target
$18.00 – $32.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $32.00 and a min estimate of $18.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$24.33
+$6.1 vs prior
Implied Upside
+125.9%
+56.5% vs prior
Analyst Covering
3
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
43%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$1.33 Gap
Median $23.00 vs avg $24.33 - a few bullish outliers are pulling the average up
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Yi Chen | HC Wainwright & Co. | Buy | Maintained | 5 days ago | Plus | Plus | Plus |
Mani Foroohar | Leerink Swann | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Brian Skorney | Baird | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
